Avant Bio

Nomic is a bioengineering company focused on enhancing access to the human proteome, similar to the accessibility of the human genome. The company is developing the next-generation ELISA platform, known as nELISA, which is designed for high-throughput protein measurement. Nomic's solutions enable scientists to conduct protein profiling efficiently, allowing them to determine the scope and scale of their experiments. The platform features a cost-effective reagent system that integrates seamlessly with existing industry cytometers, facilitating high-throughput analysis and the creation of custom protein panels. By leveraging advanced technology, Nomic aims to empower researchers and nanotechnology developers to utilize DNA as a flexible and programmable linker, effectively addressing challenges such as cross-reactivity in protein measurements.

PathPresenter is a global image-sharing platform designed specifically for the field of pathology. The company's mission is to democratize access to pathology knowledge by facilitating the sharing of image data, artificial intelligence algorithms, and specialized expertise among professionals. PathPresenter's platform offers a secure and HIPAA-compliant environment, allowing pathologists to collaborate more effectively with colleagues worldwide. This innovative approach aims to enhance the quality of care provided to patients by leveraging the collective knowledge and resources of the pathology community.

PL BioScience GmbH is a biotechnology company based in Aachen, Germany, specializing in the development and manufacture of cell culture products derived from human platelet lysate. Founded in 2015, the company provides a range of products tailored for stem cell research, including research grade, GMP grade, and customized formulations, as well as fibrinogen-depleted and gamma-irradiated products. PL BioScience also offers advanced 2D and 3D cell culture solutions, cell culture medium kits, primary cells, and related support services. Its offerings are designed to facilitate safe and reproducible cellular growth for basic research, cellular therapeutics, and clinical applications. Through its online platform, PL BioScience meets the increasing demand for high-quality cell culture media essential for various stages of research and development within the biotech and life sciences sectors.